For the Inventor, By the Inventor

Enter assignee name

Institut Pasteur De Lille

USPTO Granted Patents = 55

CIPO Patents = 6

EPO Patents = 34

Forward Citations = 261

Loading Chart...

Loading Chart...

133 inventors (with patents filed for the assignee):

Camille Locht (22 out of 35 patents)

Andre Capron (6 out of 7 patents)

Jean-Claude Sirard (5 out of 5 patents)

4. Oleg Melnyk (5 out of 8 patents)

5. Sylvie Claudette Alonso (5 out of 5 patents)

6. Nathalie Mielcarek (4 out of 8 patents)

7. Benoit Deprez (4 out of 15 patents)

8. Franco Menozzi (4 out of 4 patents)

9. Helene Gras-Masse (4 out of 6 patents)

10. Christian Sergheraert (4 out of 4 patents)

11. Andre Tartar (4 out of 7 patents)

12. Anne-Sophie Debrie (3 out of 8 patents)

13. Dominique Raze (3 out of 8 patents)

14. Bernard Mahon (3 out of 6 patents)

15. Philippe Gosset (3 out of 3 patents)

Core Competencies:

Monoclonal Antibodies

Chronic Obstructive Pulmonary Disease

Microbiome Dysregulation

Hepatitis E Virus

Bacterial Superinfections

Immunoadjuvant Compounds

Influenza Vaccine

Nonsense-Mutation-Mediated Diseases

Cytotoxic T Lymphocyte-Inducing Lipopeptides

Bordetella Strains

Mycobacterial Antigens

Genetic Markers for Alzheimer's Disease

55 patents: Sort by Forward Citations

1. 12460009 - Monoclonal antibodies specific for IL20-Rb, encoding nucleic acids thereof and methods of use thereof to treat bacterial-induced exacerbation of chronic obstructive pulmonary disease (2025-11-04),

2. 12358977 - Treatment of acute exacerbations of chronic obstructive pulmonary disease by antagonism of the IL-20R (2025-07-15),

3. 11926664 - Methods and pharmaceutical compositions for modulating monocytopoiesis (2024-03-12),

4. 11446372 - [object Object] (2022-09-20),

5. 11364219 - Methods and pharmaceutical compositions for treating microbiome dysregulations associated with circadian clock disruption (2022-06-21),

6. 11226343 - Methods and kits for diagnosing postoperative pulmonary infections in patients who underwent surgery (2022-01-18),

7. 10954299 - Methods and pharmaceutical compositions for the treatment of pulmonary bacterial infections (2021-03-23),

8. 10875896 - Hepatitis E virus ORF2 capsid polypeptides and uses thereof (2020-12-29),

9. 10736937 - Methods and pharmaceutical compositions for the treatment of bacterial superinfections post-influenza (2020-08-11),

10. 10682377 - Mutantstrains and methods of use (2020-06-16),

11. 10584383 - Mitochondrial non-coding RNAs for predicting disease progression in heart failure and myocardial infarction patients (2020-03-10),

12. 10435450 - MET receptor agonist proteins (2019-10-08),

13. 10426816 - Methods and pharmaceutical compositions for the treatment of respiratory tract infections (2019-10-01),

14. 10420827 - Vaccine for prophylaxis or treatment of an allergen-driven airway pathology (2019-09-24),

15. 10369207 - Prevention of pertussis using adenylate cyclase deficient Bordetella strains (2019-08-06),

Founded in 1894, Institut Pasteur de Lille is a biomedical research institute located in Lille, France. It is dedicated to preventing and combating infectious diseases through research, education, and public health initiatives. With a team of more than 600 scientists, the institute conducts cutting-edge research in areas such as microbiology, immunology, genetics, and epidemiology. Through collaborations and partnerships, Institut Pasteur de Lille aims to improve global health and contribute to scientific advancements for the benefit of humanity.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

55 Patents

#1 in Lille

#425 in France

#12,545 in the World

Institut Pasteur De Lille

Forward Citations = 261

133 inventors:

Camille Locht (22 out of 35 patents)

Andre Capron (6 out of 7 patents)

Jean-Claude Sirard (5 out of 5 patents)

4. Oleg Melnyk (5 out of 8 patents)

5. Sylvie Claudette Alonso (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…